医学
内科学
病态的
食管鳞状细胞癌
胃肠病学
肿瘤科
临床意义
免疫疗法
癌
癌症
作者
Ji‐Feng Feng,Liang Wang,Xun Yang,Qixun Chen,Xiangdong Cheng
出处
期刊:Ejso
[Elsevier]
日期:2024-04-08
卷期号:50 (6): 108323-108323
被引量:4
标识
DOI:10.1016/j.ejso.2024.108323
摘要
Objective The geriatric nutritional risk index (GNRI) is a novel nutrition-related indicator designed to predict the risk of clinical outcomes in various cancers. The clinical significance of risk assessment, therapeutic response, and prognostic prediction of GNRI in esophageal squamous cell carcinoma (ESCC) receiving neoadjuvant immunochemotherapy (NICT), a hot point of treatment these days, have not been documented in any research. Methods Two hundred and twenty-four cases with ESCC who underwent radical resection after NICT were retrospectively recruited. Using the calculation formula of GNRI (1.489 × albumin (g/L) + 41.7 × current weight/ideal weight), the cases were split into two cohorts. Analysis was done on the connections between GNRI and clinical outcomes, such as clinical features, postoperative complications, and pathological complete response (pCR). Prognostic factors of overall survival (OS) and disease-free survival (DFS) were also performed. Results Patients were then categorized as low (n=139) or high (n=85) group based on the threshold. After radical surgery, 67 patients achieved pCR (29.9%). Higher pCR rates were attained by patients in the high GNRI group (41.2% vs. 23.0%, P=0.004). Lower GNRI patients experienced a considerably higher severe morbidity (36.7% vs. 23.5%, P=0.040), particularly in the case of respiratory complications (28.8% vs. 14.1%, P=0.012). Compared to high GNRI patients, lower GNRI cases had inferior 3-year OS (68.5% vs. 87.3%, P=0.003) and DFS (64.8% vs. 81.5%, P=0.002). It was also discovered that GNRI was a significant independent variable of both DFS [hazard ratios (HR)=0.436, P=0.009] and OS (HR=0.294, P=0.012). Conclusion The GNRI, based on nutrition-related indicators, was independently related to postoperative complications, pCR prediction, and prognostication in ESCC receiving NICT.
科研通智能强力驱动
Strongly Powered by AbleSci AI